Eindhoven, Netherlands

Arthur Van Den Wijngaard

This inventor holds 1 USPTO granted patent. Top assignee: Akzo Nobel N.v.. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arthur Van Den Wijngaard. Retrieved from https://idiyas.com/inventor/arthur-van-den-wijngaard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Arthur Van Den Wijngaard: Innovator in Biotechnology

Introduction

Arthur Van Den Wijngaard is a notable inventor based in Eindhoven, Netherlands. He has made significant contributions to the field of biotechnology, particularly through his work on genetic promoters.

Latest Patents

Arthur holds a patent for the "Isolated human BMP-4 promoter region." This innovation is crucial for understanding gene regulation and has potential applications in various biotechnological fields.

Career Highlights

Arthur is currently employed at Akzo Nobel N.V., a leading global paints and coatings company. His work at Akzo Nobel has allowed him to apply his expertise in biotechnology to real-world applications, enhancing the company's innovative capabilities.

Collaborations

Arthur has collaborated with Rein Dijkema, a fellow professional in the field. Their partnership has fostered advancements in their respective areas of expertise.

Conclusion

Arthur Van Den Wijngaard is a distinguished inventor whose work in biotechnology continues to impact the industry positively. His contributions, particularly in genetic research, highlight the importance of innovation in science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…